✦ LIBER ✦

Suppression of natural killer cells in the presence of CD34+ blood progenitor cells and peripheral blood lymphocytes

✍ Scribed by J. Clausen; M. Enk; B. Vergeiner; K. Eisendle; A.L. Petzer; G. Gastl; E. Gunsilius

Book ID: 116277879
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 248 KB
Volume: 10
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2004.06.009

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical Applications of CD34+ Periphera

Clinical Applications of CD34+ Peripheral Blood Progenitor Cells (PBPC)

✍ Wichard Vogel; Stefan Scheding; Lothar Kanz; Wolfram Brugger 📂 Article 📅 2000 🏛 AlphaMed Press 🌐 English ⚖ 65 KB

CD34 counts to predict the adequate coll

CD34 counts to predict the adequate collection of peripheral blood progenitor cells

✍ Armitage, S; Hargreaves, R; Samson, D; Brennan, M; Kanfer, E; Navarrete, C 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 165 KB

Generation of human natural killer cells

Generation of human natural killer cells from peripheral blood CD34+ cells mobilized by granulocyte colony-stimulating factor

✍ Katsuto Takenaka; Shin-ichi Mizuno; Mine Harada; Koji Nagafuji; Toshihiro Miyamo 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 426 KB

Effect of CD34+ peripheral blood progeni

Effect of CD34+ peripheral blood progenitor cell dose on hematopoietic recovery

✍ Elizabeth J Shpall; Richard Champlin; John A Glaspy 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 128 KB

Osmotic tolerance of human peripheral bl

Osmotic tolerance of human peripheral blood lymphocytes and progenitor cells

✍ P. Law; P. Alsop; D.C. Dooley; H.T. Meryman 📂 Article 📅 1982 🏛 Elsevier Science 🌐 English ⚖ 110 KB

Targeted transduction of CD34+ hematopoi

Targeted transduction of CD34+ hematopoietic progenitor cells in nonpurified human mobilized peripheral blood mononuclear cells

✍ Min Liang; Nonia Pariente; Kouki Morizono; Irvin S. Y. Chen 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 973 KB

## Abstract ## Background Conventional gene‐therapy applications of hematopoietic stem cells (HSCs) involve purification of CD34+ progenitor cells from the mobilized peripheral blood, __ex vivo__ transduction of the gene of interest into them, and reinfusion of the transduced CD34+ progenitor cell